Patent · US Active

Three-dimensionally printed blood glucose sensing device and fabrication method

US10939857B2 · kind B2 · utility

1Cited by
2References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 19, 2018
Grant dateMar 9, 2021
Priority date
Expiry dateJan 5, 2039

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/49
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A blood glucose sensing device includes a substrate, multiple three-dimensionally (3D) printed electrode leads comprising graphene arranged on or over the substrate, and glucose monitoring chemistry arranged in or on (e.g., adsorbed in) at least one of the 3D printed electrode leads. An end portion of a counter electrode lead may partially surround an end portion of a working electrode lead, and a reference lead may be further provided, Optionally, the 3D printed electrode leads may include a thermoplastic material, such as an aliphatic polyester. The glucose monitoring chemistry may include an enzyme.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.